The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2022 | Unmet needs in radiotherapy for small cell lung cancer
Bjorn Henning Gronberg, MD, PhD, Norwegian University of Science and Technology, Trondheim, Norway, discusses the need to establish a classification system for patients with small cell lung cancer, in order to better personalise treatments. Prof. Gronberg also talks on the difficulty of collecting enough tissue samples from these patients, and the possibility of liquid biopsy being a solution to this problem. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
